It would be interesting to determine if any loss-of-function genetic variants of lrp10 can be identified in female APOE4+/- AD subjects and how LRP10 modulates the development of AD in sex-specific manners in relation to other APOE receptors and/or downstream signaling pathways in future studies. This evidence concerns the gene APOE and Alzheimer disease.